BioXcel Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.30-$4.17
Market Cap
$16.4M
Shares Short
898,726

Financials

See more
Revenue (12 Mos)
$2.4M
Revenue Growth (YoY)
141.6%
Gross Profit (12 Mos)
$355,000
Diluted EPS
-$2.04

News

See more

Yahoo Finance • last year

BioXcel Therapeutics to Host Virtual Neuroscience R&D Day on Dec. 12, 2023

Yahoo Finance • last year

BioXcel Therapeutics Inc (BTAI) Reports Q3 2023 Financial Results and Strategic Updates

Yahoo Finance • last year

BioXcel Therapeutics Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter 2023 Financial Results

Yahoo Finance • last year

BioXcel Therapeutics Reports Positive Overall Survival Results from Single-Arm, Open-Label Phase 2 Trial of BXCL701 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) of Adenocarcinoma Phenotype

About

CEO
Dr. Vimal D. Mehta Ph.D.
CFO
Mr. Richard I. Steinhart MBA
Address
555 Long Wharf Drive, New Haven, CT, United States, 06511
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
74